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Cloudy  peritoneal  dialysate  ef
syndrome
Eﬂuente  peritoneal  turbio  debido  a
al  injerto  renal
To the Editor,The presence of cloudy peritoneal ﬂuid (PF) in patients on
peritoneal dialysis (PD) usually occurs in the context of infec-
tious peritonitis. For this diagnosis, two of the following three
criteria must be met: (1) the presence of abdominal pain,
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ent due  to graft intolerance
n  síndrome  de  intolerancia
(2) cloudy ﬂuid with more  than 100 leukocytes/L and more
than 50% of them polymorphonucleocytes, and (3) positivelina-Vila P, Montomoli M, Pallardó-Mateu LM, Ávila-Bernabeu A.
rto renal. Nefrologia. 2016;36:198–199.
high cell count. Inﬂammation of juxtaperitoneal organs (pan-
creatitis, cholecystitis, splenic infarct, appendicitis, etc.) can
increase the number of polymorphonuclear lymphocytes in
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PF. An increase in PF lymphocytes has also been described
with the use of icodextrin,2 tuberculous peritonitis, viral
gastroenteritis,3 and in one case of acute rejection in graft
failure,4 all with negative PF culture. We describe a new case
of cloudy PF with a predominance of lymphocytes and neg-
ative culture in a patient with a non-functioning renal graft
on PD.
This was a 67-year-old man  with chronic kidney disease
of unknown aetiology, who started haemodialysis in 2005,
and in January 2009 received a renal graft from a cadaveric
donor. Six months post-transplant, a renal biopsy was done
because of graft dysfunction and a diagnosis was made of
nephritis secondary to BK polyomavirus. The patient con-
tinued with the dysfunctional graft until March 2012 when
he restarted haemodialysis. After 3 months of haemodial-
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Discussion
Cloudy PF in PD can be due to multiple causes. Although
the most common cause is infectious peritonitis, other
possibilities should be considered. The management of
immunosuppression in transplant patients starting PD is con-
troversial; maintenance immunosuppression can increase the
incidence of infection and neoplasia, but its withdrawal leads
to accelerated loss of residual renal function and the possible
occurrence of graft intolerance syndrome. In this patient with
signiﬁcant cumulative immunosuppression, as soon as cloudy
PF was noted, infectious peritonitis was the main diagnosis of
suspicion. However, as we  have seen, if not all the criteria for
infectious peritonitis are present, and above all, there is a pre-
dominance of lymphocytes in the PF, we  must look for other
r
1
2
3
4
5sis, the patient expressed his wish to be transferred to
D and in July 2012 he started continuous ambulatory PD
CAPD). At that time, the patient was receiving 1 mg/day
f tacrolimus (blood level 4 mg/dL), prednisolone had been
topped 2 months before starting PD, and he had a residual
iuresis of 500–700 mL/day. As the patient had had viraemia
ositive for BK virus, and therefore could not be re-added
o the waiting list, we decided to stop tacrolimus to try to
et a negative viral load.5 Two months later, the patient pre-
ented with symptoms of diffuse abdominal pain, worst in the
one of the graft, with a low-grade fever, and cloudy PF. Diure-
is had decreased to 400 mL/day, and there was no failure of
ltraﬁltration with his regular CAPD routine. Physical exam
evealed mild tenderness on palpation of the graft, with no
eritonism. Blood tests showed anaemia despite high doses
f erythropoietic agents and a CRP of 185 mg/L, and there
ere no signs of systemic infection. Urine had minimal pro-
einuria and haematuria without leukocyturia. The PF cell
ount showed 300 leukocytes/L with 35.7% polymorphonu-
leocytes and 64.3% lymphocytes. Doppler-echo conﬁrmed
he presence of graft ﬂow. Due to the apparent clinical pic-
ure of graft intolerance and lack of criteria for a diagnosis
f infectious peritonitis, we decided to start treatment with
orticoids at a dose of 0.5 mg/kg/day without adding intraperi-
oneal antibiotics. Forty-eight hours later, the patient showed
 signiﬁcant clinical improvement with resolution of pain at
he graft site and resolution of the cloudy PF. Subsequently,
ll cultures, including PF, were conﬁrmed negative. Peritoneal
uid cytology was performed with immunohistochemistry
echniques and ﬂow cytometry, showing a predominance of
 lymphocytes (CD-3 positive). Finally, in March 2013 we per-
ormed graft embolisation, after a biopsy. The biopsy showed
umoral rejection with vasculitis, tubulitis, and presence of
4d in the peritubular capillaries. Following a reducing dose
f steroids and graft embolisation, the patient had no further
loudy PF, and negative cultures as long as he remained on
D.causes of cloudy PF. We  think that graft intolerance must be
in the differential diagnosis of cloudy PF in patients with a
dysfunctional renal graft on PD.
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